StonvexLoading…
StonvexStonvexStonvexCore line items from JELD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-28 | Annual 2025 2025-12-31 | Q3 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $722.13M | $3.21B | $2.41B | $1.60B |
Operating Income | $-55.22M | $-416.04M | $-401.40M | $-198.88M |
Net Income | $-76.84M | $-621.21M | $-579.26M | $-211.66M |
EPS (Diluted) | $-0.90 | $-7.29 | $-6.80 | $-2.49 |
Total Assets | $2.08B | $2.10B | $2.17B | $2.54B |
Total Liabilities | $2.07B | $2.01B | $2.06B | $2.07B |
Cash & Equivalents | $50.36M | $136.10M | $106.68M | $134.11M |
Free Cash Flow OCF − CapEx | $-116.31M | $-124.62M | $-128.04M | $-114.95M |
Shares Outstanding | 86.12M | 85.49M | 85.41M | 85.34M |